Company: SMNR
Filing Date: 2025-06-11
Form Type: S-4/A
Source: 0001193125-25-139124
Chunk: 332

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-06-11
Form: S-4/A
Chunk 332
---
,258 |     |           | — |     |              |  70,220 |
| Pfizer Inc. (NYSE:PFE)                             |     |               |  28.85 |     |             | 5,667 |     |           | — |     |              | 163,484 |
| Eli Lilly and Company (NYSE:LLY)                   |     |               | 908.05 |     |             |   900 |     |           | — |     |              | 817,632 |
| Viatris Inc. (NasdaqGS:VTRS)                       |     |               |  11.57 |     |             | 1,194 |     |           | — |     |              |  13,809 |
| Teva Pharmaceutical Industries Limited (NYSE:TEVA) |     |               |  17.13 |     |             | 1,133 |     |           | — |     |              |  19,408 |
| Dr. Reddy’s Laboratories Limited (BSE:500124)      |     |               |  81.03 |     |             |   167 |     |           | — |     |              |  13,498 |
| Collegium Pharmaceutical, Inc. (NasdaqGS:COLL)     |     |               |  36.71 |     |             |    32 |     |           | — |     |              |   1,183 |
| AbbVie Inc. (NYSE:ABBV)                            |     |               | 191.23 |     |             | 1,766 |     |           | — |     |              | 337,778 |
| Axsome Therapeutics, Inc. (NasdaqGM:AXSM)          |     |               |  84.85 |     |             |    48 |     |           | — |     |              |   4,073 |

Notes:

| (1) | Values in thousands of US dollars, except stock price per share and shares outstanding. |

| (2) | Corresponding values continued in table below. |

| (3) | Source: S&P Capital IQ. |

188

Comparable Company Information (Continued)

| Comparable Company Names                           |     | Total    
 Interest 
 Bearing  
 Debt($)  |        |     | Total      
 Invested   
 Capital($) |         |     | Less: Cash($) |